Overall unmet information needs | Unmet information needs at hospital discharge# | Unmet information needs in handovers between internal hospital departments## | Unmet information needs in handovers between hospitals### | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N (%) | OR (95% CI) | ORadja(95% CI) | N (%) | OR (95% CI) | ORadja(95% CI) | N (%) | OR (95% CI) | ORadja(95% CI) | N (%) | OR (95% CI) | ORadja(95% CI) | |
Demographic characteristics | ||||||||||||
Gender | ||||||||||||
Women | 19 (19%) | 1.00 | 1.00 | 14 (16%) | 1.00 | 1.00 | 8 (12%) | 1.00 | 1.00 | 12 (13%) | 1.00 | 1.00 |
Men | 4 (12%) | 0.57 (0.18; 1.83) | 1.10 (0.31; 3.93) | 4 (25%) | 1.71 (0.48; 6.09) | 2.24 (0.58; 8.64) | 3 (21%) | 2.05 (0.47; 8.94) | 3.31 (0.66; 16.59) | 4 (12%) | 0.97 (0.29; 3.23) | 2.77 (0.63; 11.20) |
Age | ||||||||||||
<60 years of age | 13 (33%) | 1.00 | 1.00 | 9 (26%) | 1.00 | 1.00 | 6 (23%) | 1.00 | 1.00 | 9 (24%) | 1.00 | 1.00 |
≥60 years of age | 10 (11%) | 0.24*(0.10; 0.62) | 0.26*(0.10; 0.70) | 9 (13%) | 0.42 (0.15; 1.19) | 0.36 (0.12; 1.07) | 5 (9%) | 0.33 (0.09; 1.19) | 0.26 (0.07; 1.05) | 7 (8%) | 0.27*(0.09; 0.79) | 0.23*(0.07; 0.80) |
Marital status | ||||||||||||
No partner | 8 (29%) | 1.00 | 1.00 | 7 (29%) | 1.00 | 1.00 | 2 (13%) | 1.00 | 1.00 | 5 (19%) | 1.00 | 1.00 |
Partner | 15 (15%) | 0.43 (0.16; 1.16) | 0.39 (0.13; 1.16) | 11 (14%) | 0.40 (0.13; 1.18) | 0.39 (0.12; 1.24) | 9 (13%) | 1.01 (0.19; 5.23) | 0.63 (0.10; 3.78) | 11 (11%) | 0.54 (0.17; 1.71) | 0.47 (0.12; 1.88) |
Education | ||||||||||||
Not higher education | 7 (10%) | 1.00 | 1.00 | 6 (12%) | 1.00 | 1.00 | 4 (9%) | 1.00 | 1.00 | 2 (3%) | 1.00 | 1.00 |
Higher education | 16 (29%) | 3.60*(1.36; 9.52) | 3.41*(1.23; 9.44) | 12 (24%) | 2.43 (0.83; 7.11) | 2.53 (0.84; 7.59) | 7 (19%) | 2.28 (0.61; 8.49) | 2.72 (0.67; 11.09) | 14 (26%) | 11.90*(2.57; 55.08) | 13.88*(2.78; 67.23) |
Clinical characteristics | ||||||||||||
Comorbidity | ||||||||||||
No comorbidity | 8 (20%) | 1.00 | 1.00 | 6 (19%) | 1.00 | 1.00 | 4 (14%) | 1. 00 | 1.00 | 4 (10%) | 1.00 | 1.00 |
Yes comorbidity | 15 (16%) | 0.79 (0.30; 2.07) | 1.35 (0.45; 4.05) | 12 (18%) | 0.93 (0.31; 2.75) | 1.33 (0.40; 4.38) | 7 (14%) | 1.02 (0.27; 3.82) | 2.17 (0.43; 10.91) | 12 (14%) | 1.46 (0.44; 4.85) | 3.51 (0.82; 15.09) |
Treatment | ||||||||||||
Surgery | ||||||||||||
No surgery | 3 (9%) | 1.00 | 1.00 | 3 (21%) | 1.00 | 1.00 | 3 (20%) | 0.55 | 1.00 | 3 (9%) | 1.00 | 1.00 |
Surgery | 20 (21%) | 2.72 (0.75; 9.81) | 2.98 (0.35; 25.77) | 15 (17%) | 0.76 (0.19; 3.07) | 1.21 (0.12; 12.24) | 8 (12%) | 0.54 (0.13; 2.35) | 0.63 (0.02; 15.89) | 13 (14%) | 1.66 (0.44; 6.22) | 3.30 (0.23; 46.73) |
Radiation | ||||||||||||
No radiation | 10 (20%) | 1.00 | 1.00 | 10 (30%) | 1.00 | 1.00 | 2 (15%) | 1.00 | 1.00 | 7 (14%) | 1.00 | 1.00 |
Radiation | 13 (16%) | 0.81 (0.32; 2.01) | 0.73 (0.26; 2.01) | 8 (12%) | 0.31*(0.11; 0.87) | 0.33 (0.11; 1.01) | 9 (13%) | 0.83 (0.16; 4.35) | 0.75 (0.13; 4.42) | 9 (12%) | 0.83 (0.29; 2.40) | 0.93 (0.28; 3.11) |
Chemotherapy | ||||||||||||
No chemotherapy | 8 (13%) | 1.00 | 1.00 | 7 (17%) | 1.00 | 1.00 | 5 (14%) | 1.00 | 1.00 | 8 (13%) | 1.00 | 1.00 |
Chemotherapy | 15 (22%) | 1.91 (0.75; 4.88) | 1.10 (0.30; 4.06) | 11 (18%) | 1.09 (0.38; 3.09) | 1.21 (0.31; 4.82) | 6 (13%) | 0.98 (0.27; 3.53) | 1.15 (0.18; 7.53) | 8 (12%) | 0.93 (0.33; 2.65) | 0.43 (0.08; 2.26) |
Hormones | ||||||||||||
No hormones | 8 (27%) | 1.00 | 1.00 | 6 (26%) | 1.00 | 1.00 | 3 (19%) | 1.00 | 1.00 | 3 (10%) | 1.00 | 1.00 |
Hormones | 15 (15%) | 0.49 (0.18; 1.29) | 0.45 (0.15; 1.33) | 12 (15%) | 0.52 (0.17; 1.57) | 0.50 (0.15; 1.67) | 8 (12%) | 0.60 (0.14; 2.57) | 0.50 (0.10; 2.52) | 13 (13%) | 1.31 (0.35; 4.95) | 1.38 (0.30; 6.40) |
Years since diagnosis | ||||||||||||
<3 years | 11 (18%) | 1.00 | 1.00 | 7 (16%) | 1.00 | 1.00 | 6 (15%) | 1.00 | 1.00 | 9 (16%) | 1.00 | 1.00 |
≥3 years | 12 (17%) | 0.92 (0.37; 2.27) | 0.99(0.35; 2.78) | 11 (19%) | 1.26 (0.45;3.58) | 1.65(0.50; 5.47) | 5 (12%) | 0.81 (0.23; 2.90) | 1.00 (0.24; 4.15) | 7 (10%) | 0.60 (0.21; 1.74) | 0.81(0.23; 2.87) |